Y32* (p.Tyr32Ter) variant of HRAS (GTPase HRas)
Y32* (p.Tyr32Ter) in HRAS (GTPase HRas) is a protein-truncating change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.30 / 1. The record also includes population frequency data and structural context.
Y32* (p.Tyr32Ter) variant details
- p.Tyr32Ter
- cosmic curated COSV54236
- ESP rs369039481
- ExAC rs369039481
- gnomAD rs369039481
- Likely benign
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.3
- CADD 31.00
- EBI: Likely benign
- UniProt: Likely benign
- Population evidence available
- Structural context available